Find the right fit for you - faster
Get tailored insights about working at Helix in one quick step.
Helix Snapshot
Helix's mission is to empower every person to improve their life through DNA. We believe in a world where every person benefits from their biological information and is able to help all of humanity lead better lives.
Helix is a rapidly growing population genomics company working at the intersection of clinical care, research, and genomics.
Founded in 2015 with a mission to “empower every person to improve their life through their DNA”, our end-to-end population genomics platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into routine clinical care. Powered by one of the world’s largest CLIA / CAP next-generation sequencing labs and our proprietary Exome+® assay, we support all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.
We help our partners use genomics to improve health outcomes, increase patient engagement, lower costs, and drive cutting edge translational and clinical research. For the individual, we store and protect their DNA information so that they control their data and can use it throughout their lifetime in a variety of settings.
Leading health systems, including Renown Health, AdventHealth, and Mayo Clinic, use our population genomics platform to power some of the world’s largest and fastest-growing population genomics initiatives.
We also collaborate with our health system partners to combine longitudinal EHR data with genomic data to optimize care across the health system. This proprietary clinico-genomic dataset, with recontactable individuals and actively enrolling programs, powers our life sciences segment and helps our life sciences partners bring innovative therapies to patients faster and more efficiently.
Founded in 2015 with a mission to “empower every person to improve their life through their DNA”, our end-to-end population genomics platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into routine clinical care. Powered by one of the world’s largest CLIA / CAP next-generation sequencing labs and our proprietary Exome+® assay, we support all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.
We help our partners use genomics to improve health outcomes, increase patient engagement, lower costs, and drive cutting edge translational and clinical research. For the individual, we store and protect their DNA information so that they control their data and can use it throughout their lifetime in a variety of settings.
Leading health systems, including Renown Health, AdventHealth, and Mayo Clinic, use our population genomics platform to power some of the world’s largest and fastest-growing population genomics initiatives.
We also collaborate with our health system partners to combine longitudinal EHR data with genomic data to optimize care across the health system. This proprietary clinico-genomic dataset, with recontactable individuals and actively enrolling programs, powers our life sciences segment and helps our life sciences partners bring innovative therapies to patients faster and more efficiently.
